Drug intelligence / Profile preview

erzhi-tiangui granules

Development stage
Preclinical
Lead developer
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Erzhi-tiangui granules (ETG) is a traditional Chinese medicine (TCM) herbal formula developed as a proprietary hospital preparation by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine. Based on the TCM principle of replenishing vital essence to tonify the kidney, the formula consists of ten herbal ingredients, including Ligustrum lucidum (Nv Zhen Zi), Eclipta prostrata (Han Lian Cao), Lycium barbarum (Gou Qi Zi), Cuscuta chinensis (Tu Si Zi), Rehmannia glutinosa (Shu Di Huang), Angelica sinensis (Dang Gui), Paeonia lactiflora (Bai Shao), Ligusticum striatum (Chuan Xiong), Cyperus rotundus (Xiang Fu), and Glycyrrhiza uralensis (Zhi Gan Cao). Erzhi-tiangui granules are primarily used to improve female fertility, optimize oocyte and embryo quality, and enhance in vitro fertilization (IVF) outcomes in women with diminished ovarian reserve (DOR), poor ovarian response (POR), or advanced maternal age. The therapeutic mechanism is associated with the downregulation of granulosa cell apoptosis and oxidative stress, potentially mediated by the upregulation of the long non-coding RNA NEAT1 and the Nrf2/HO-1 signaling pathway, leading to the subsequent modulation of apoptotic factors such as Bcl-2, Caspase-3, Bax, and FOXO3a.

Other names
EZTGEZTGFErzhi Tiangui GranuleErzhi Tiangui formulaErzhi Tiangui granuleserzhi-tiangui formula

Beyond the preview

Go deeper on erzhi-tiangui granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on erzhi-tiangui granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call